Robert Gurny
22Patents
6h-index
34Co-inventors
69Inventor score
Filing activity: Dec 9, 1988 → Feb 14, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5773021A | Bioadhesive ophthalmic insert | Human Necessities | 68 | Expired |
| US4968350A | Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereof | Human Necessities | 48 | Expired |
| US6440460B1 | Pharmaceutical compositions containing buffered ortho ester polymers | Human Necessities | 25 | Expired |
| US6319512A | Implants for controlled release of pharmaceutically active principles and method for making same | Human Necessities | 23 | Expired |
| US8741877B2 | Polylactides compositions and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US6245346A | Pharmaceutical compositions for the sustained release of insoluble active principles | Human Necessities | 9 | Expired |
| US7455858B2 | Compositions and methods for delivery of photosensitive drugs | Human Necessities | 3 | Expired |
| US6589999B2 | Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media | Human Necessities | 3 | Expired |
| US8466133B2 | Polylactides compositions and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8945609B2 | Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same | Chemistry; Metallurgy | 2 | Active |
| US9155745B2 | Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs | Human Necessities | 1 | Active |
| US8507563B2 | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same | Chemistry; Metallurgy | 1 | Active |
| US10093726B2 | Protein sustained-release injectable formulation | Chemistry; Metallurgy | 0 | Active |
| US8835514B2 | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same | Chemistry; Metallurgy | 0 | Active |
| US9055722B2 | Product for use in agriculture or horticulture | Human Necessities | 0 | Active |
| US9549985B2 | Compositions comprising polymers prepared from 2-hydroxyalkyl acids | Chemistry; Metallurgy | 0 | Active |
| US9375482B2 | Polylactide compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10314913B2 | Polylactide compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9925267B2 | Polylactide compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9468683B2 | Hybrid hydrogels | Human Necessities | 0 | Active |
| US9873736B2 | Protein sustained-release injectable formulation | Chemistry; Metallurgy | 0 | Active |
| US8835571B2 | Fatty acid derivative-polymer conjugate | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.